Veracyte, Inc.

VCYTNASDAQ • USD
24.33 USD
↘ 0.30 (1.22%)AT CLOSE (03:59 PM EST)
23.71
↘ 0.62 (2.55%)
POST MARKET (AS OF 04:15 PM EST)
Post Market
AS OF 04:15 PM EST
23.71
↘ 0.62 (2.55%)
🔴Market: CLOSED

Veracyte, Inc. (VCYT) is currently trading at $24.33. The technical outlook is "Strong Sell" and the fundamental picture shows "Neutral". This is driven by a robust Altman Z-Score, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest VCYT is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Nov 13, 2026.

Open?$24.49
High?$24.65
Low?$23.45
Prev. Close?$24.63
Volume?2.0M
Avg. Volume?2.2M
VWAP?$24.20
Rel. Volume?0.91x
Bid / Ask
Bid?$23.00 × 100
Ask?$24.30 × 1.1K
Spread?$1.30
Midpoint?$23.65
Valuation & Ratios
Market Cap?2.0B
Shares Out?80.4M
Float?79.9M
Float %?99.4%
P/E Ratio?15.48
P/B Ratio?1.37
EPS?$1.57
Dividend?0.00%
Ex-Dividend?N/A
RelatedWSTGMED
News
Profile
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).
Employees
755
Market Cap
2.0B
Industry
SERVICES-MEDICAL LABORATORIES
Listed
2013-10-30
Address
6000 SHORELINE COURT, SUITE 300
SOUTH SAN FRANCISCO, CA 94080
Phone: (650) 243-6300
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
100
Momentum?
48
Short Sent.?
54
Piotroski F-Score?4/9Mixed
Altman Z-Score?16.15Safe
Confidence?59%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?11.96%High
Short Interest?9.6M
Days to Cover?8.2
Free Float79.9M
Avg Daily Volume1.2M
Settlement Date2026-10-30
Financial Health
Current Ratio?5.56Strong
Quick Ratio?5.25Strong
Cash Ratio?2.37Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 2 peers + S&P 500
Score
83/100
P/E?
Peers
100
S&P
79
15.5CHEAP▾
P/B?
Peers
100
S&P
90
1.37CHEAP▾
P/S?
Peers
67
S&P
46
3.37FAIR▾
P/FCF?
Peers
100
S&P
83
12.1CHEAP▾
EV/EBITDA?
Peers
67
S&P
53
14.6FAIR▾
EV/Sales?
Peers
67
S&P
60
3.03FAIR▾
Returns & Efficiency
ROE?
Peers
33
S&P
29
8.9%FAIR▾
ROA?
Peers
33
S&P
66
8.1%STRONG▾
Cash Flow & Enterprise
FCF?$161.9M
Enterprise Value?$1.8B
Fundamentals ratios updated end of day